328 related articles for article (PubMed ID: 20404274)
21. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
Fanales-Belasio E; Moretti S; Fiorelli V; Tripiciano A; Pavone Cossut MR; Scoglio A; Collacchi B; Nappi F; Macchia I; Bellino S; Francavilla V; Caputo A; Barillari G; Magnani M; Laguardia ME; Cafaro A; Titti F; Monini P; Ensoli F; Ensoli B
J Immunol; 2009 Mar; 182(5):2888-97. PubMed ID: 19234184
[TBL] [Abstract][Full Text] [Related]
22. The myeloid cytokine network in AIDS pathogenesis.
Mir KD; Mavigner M; Silvestri G
Cytokine Growth Factor Rev; 2012; 23(4-5):223-31. PubMed ID: 22748236
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases.
Michlmayr D; Pak TR; Rahman AH; Amir ED; Kim EY; Kim-Schulze S; Suprun M; Stewart MG; Thomas GP; Balmaseda A; Wang L; Zhu J; Suaréz-Fariñas M; Wolinsky SM; Kasarskis A; Harris E
Mol Syst Biol; 2018 Aug; 14(8):e7862. PubMed ID: 30150281
[TBL] [Abstract][Full Text] [Related]
24. Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection.
Cho B; Jeon BY; Kim J; Noh J; Kim J; Park M; Park S
Yonsei Med J; 2008 Oct; 49(5):828-35. PubMed ID: 18972604
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004.
Sergon K; Njuguna C; Kalani R; Ofula V; Onyango C; Konongoi LS; Bedno S; Burke H; Dumilla AM; Konde J; Njenga MK; Sang R; Breiman RF
Am J Trop Med Hyg; 2008 Feb; 78(2):333-7. PubMed ID: 18256441
[TBL] [Abstract][Full Text] [Related]
26. Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion.
Rios M; Zhang MJ; Grinev A; Srinivasan K; Daniel S; Wood O; Hewlett IK; Dayton AI
Transfusion; 2006 Apr; 46(4):659-67. PubMed ID: 16584445
[TBL] [Abstract][Full Text] [Related]
27. Characterization of reemerging chikungunya virus.
Sourisseau M; Schilte C; Casartelli N; Trouillet C; Guivel-Benhassine F; Rudnicka D; Sol-Foulon N; Le Roux K; Prevost MC; Fsihi H; Frenkiel MP; Blanchet F; Afonso PV; Ceccaldi PE; Ozden S; Gessain A; Schuffenecker I; Verhasselt B; Zamborlini A; Saïb A; Rey FA; Arenzana-Seisdedos F; Desprès P; Michault A; Albert ML; Schwartz O
PLoS Pathog; 2007 Jun; 3(6):e89. PubMed ID: 17604450
[TBL] [Abstract][Full Text] [Related]
28. Phenotype and function of myeloid dendritic cells derived from African green monkey blood monocytes.
Mortara L; Ploquin MJ; Faye A; Scott-Algara D; Vaslin B; Butor C; Hosmalin A; Barré-Sinoussi F; Diop OM; Müller-Trutwin MC
J Immunol Methods; 2006 Jan; 308(1-2):138-55. PubMed ID: 16325847
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D modulates the expression of Toll-like receptors and pro-inflammatory cytokines without affecting Chikungunya virus replication, in monocytes and macrophages.
Valdés-López JF; Velilla P; Urcuqui-Inchima S
Acta Trop; 2022 Aug; 232():106497. PubMed ID: 35508271
[TBL] [Abstract][Full Text] [Related]
30. Chikungunya and the nervous system: what we do and do not know.
Arpino C; Curatolo P; Rezza G
Rev Med Virol; 2009 May; 19(3):121-9. PubMed ID: 19274635
[TBL] [Abstract][Full Text] [Related]
31. Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection.
Roques P; Thiberville SD; Dupuis-Maguiraga L; Lum FM; Labadie K; Martinon F; Gras G; Lebon P; Ng LFP; de Lamballerie X; Le Grand R
Viruses; 2018 May; 10(5):. PubMed ID: 29772762
[TBL] [Abstract][Full Text] [Related]
32. Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus.
Tiwari M; Parida M; Santhosh SR; Khan M; Dash PK; Rao PV
Vaccine; 2009 Apr; 27(18):2513-22. PubMed ID: 19368794
[TBL] [Abstract][Full Text] [Related]
33. Monocyte and dendritic cell recruitment and activation during oral Salmonella infection.
Wick MJ
Immunol Lett; 2007 Oct; 112(2):68-74. PubMed ID: 17720254
[TBL] [Abstract][Full Text] [Related]
34. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.
Hawman DW; Stoermer KA; Montgomery SA; Pal P; Oko L; Diamond MS; Morrison TE
J Virol; 2013 Dec; 87(24):13878-88. PubMed ID: 24131709
[TBL] [Abstract][Full Text] [Related]
35. Modulation of monocytic cell activity and virus susceptibility during differentiation into macrophages.
Basta S; Knoetig SM; Spagnuolo-Weaver M; Allan G; McCullough KC
J Immunol; 1999 Apr; 162(7):3961-9. PubMed ID: 10201916
[TBL] [Abstract][Full Text] [Related]
36. Mouse macrophage innate immune response to Chikungunya virus infection.
Kumar S; Jaffar-Bandjee MC; Giry C; Connen de Kerillis L; Merits A; Gasque P; Hoarau JJ
Virol J; 2012 Dec; 9():313. PubMed ID: 23253140
[TBL] [Abstract][Full Text] [Related]
37. Chikungunya virus pathogenesis and immunity.
Gasque P; Couderc T; Lecuit M; Roques P; Ng LF
Vector Borne Zoonotic Dis; 2015 Apr; 15(4):241-9. PubMed ID: 25897810
[TBL] [Abstract][Full Text] [Related]
38. The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation.
Wauquier N; Becquart P; Nkoghe D; Padilla C; Ndjoyi-Mbiguino A; Leroy EM
J Infect Dis; 2011 Jul; 204(1):115-23. PubMed ID: 21628665
[TBL] [Abstract][Full Text] [Related]
39. Chikungunya virus infection.
Sam IC; AbuBakar S
Med J Malaysia; 2006 Jun; 61(2):264-9. PubMed ID: 16898330
[TBL] [Abstract][Full Text] [Related]
40. Artificially generated dendritic cells misdirect antiviral immune responses.
Noone C; Manahan E; Newman R; Johnson P
J Leukoc Biol; 2007 Apr; 81(4):952-6. PubMed ID: 17267762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
